13G Filing: Broadfin Capital and Cidara Therapeutics Inc. (CDTX)

Page 10 of 10

Page 10 of 10 – SEC Filing

EXHIBIT A
Broadfin Capital, LLC is the relevant entity for which Kevin Kotler may be considered a control person.

SK 25125 0001 7562572

Follow Cidara Therapeutics Inc. (NASDAQ:CDTX)

Page 10 of 10